Keyphrases
Hematopoietic Stem Cell Transplantation
100%
Chronic Inflammatory Demyelinating Polyradiculoneuropathy
100%
Disability
14%
Randomized Trial
14%
Overall Survival
14%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
14%
Remission
14%
Left-handed
14%
Cyclophosphamide
14%
Immune Therapy
14%
Ambulation
14%
Rituximab
14%
Grip Strength
14%
Medication-free
14%
Intravenous Immunoglobulin (IVIg)
14%
Peripheral Blood Stem Cells
14%
Treatment-related Mortality
14%
Thymoglobulin
14%
Nerve Conduction Velocity
14%
Plasmapheresis
14%
Compound muscle Action Potential
14%
Medicine and Dentistry
Hematopoietic Stem Cell Transplantation
100%
Polyradiculoneuropathy
100%
Overall Survival
14%
Cyclophosphamide
14%
Thymocyte Antibody
14%
Hand Grip
14%
Rituximab
14%
Peripheral Blood Stem Cell
14%
Autologous Hematopoietic Stem Cell Transplantation
14%
Plasmapheresis
14%
Conditioning
14%
Immunotherapy
14%
Action Potential
14%
Nerve Conduction Velocity
14%
Pharmacology, Toxicology and Pharmaceutical Science
Polyradiculoneuropathy
100%
Overall Survival
33%
Remission
33%
Cyclophosphamide
33%
Rituximab
33%
Thymocyte Antibody
33%
Immunotherapy
33%
Immunology and Microbiology
Hematopoietic Stem Cell Transplantation
100%
Overall Survival
14%
Conditioning
14%
Intravenous Immunoglobulin
14%
Rituximab
14%
Nerve Conduction
14%
Action Potential
14%
Anti-Thymocyte Globulin
14%
Autologous Hematopoietic Stem Cell Transplantation
14%
Peripheral Blood Stem Cell
14%
Plasmapheresis
14%
Grip Strength
14%
Immunotherapy
14%
Cyclophosphamide
14%
Neuroscience
Hematopoietic Cell
100%
Intravenous Immunoglobulin
12%
Cyclophosphamide
12%
Anti-Thymocyte Globulin
12%
Stem Cell
12%
Nerve Conduction
12%
Rituximab
12%
Action Potential
12%
Immunotherapy
12%